
GeneCentric
Developer of a molecular diagnostic platform designed to characterize tumor biology in a manner that facilitates optimal targeting of therapeutic compounds. The company's platform engages in developin...
Valuation
$40M
Latest known
Share Price
N/A
Total Raised
$28.1M
Last Round
N/A